Effect of mesenchymal stromal cells‐derived extracellular vesicles as a treatment to heal diabetic wounds: A meta‐analysis

A meta‐analysis study to assess the influence of mesenchymal stromal cells‐derived extracellular vesicles (MSC‐EVs) as a treatment to heal the diabetic wound (DW). A comprehensive literature examination till February 2023 was implemented and 2975 linked studies were appraised. The picked studies contained 381 animals with diabetes mellitus in the picked studies' baseline, 217 of them were using MSC‐EVs, and 173 were using control. Odds ratio in addition to 95% confidence intervals (CIs) were used to calculate the consequence of MSC‐EVs as a therapy to heal DWs by the dichotomous and continuous styles and a fixed or random model. MSCs‐EVs had a significantly higher rate of wound closure of DWs (Mean deviation [MD], 22.20; 95% CI, 19.16–25.24, P < .001), lower width of the scar (MD, −2.57; 95% CI, −3.35 to −1.79, P < .001), higher collagen deposition (MD, 30.82; 95% CI, 20.77–40.86, P < .001), and a higher rate of re‐epithelialisation (MD, 34.36; 95% CI, 20.13–48.58, P < .001) compared with the control. MSCs‐EVs had a significantly higher rate of wound closure of DWs, lower width of the scar, higher collagen deposition, and higher rate of re‐ epithelialisation compared with the control. Although precautions should be taken when commerce with the consequences because all of the picked studies for this meta‐analysis was with low sample sizes.